Peripal closes Series B Financing Round

 

A few weeks after Peripal received marketing approval for its patient aid device for home dialysis, the medtech start-up closed a financing round to drive market expansion. With FortyOne Group a new anchor investor joined existing investors.

 

Home care is paramount to managing costs and productivity in future healthcare markets. The vision of Peripal AG is to allow more patients to be treated at home and to reduce healthcare costs in the area of dialysis. The company’s first product on the market, the PeriSafe system, solves the most problematic therapy step in home peritoneal dialysis: Patients need to perform a manual connection of tubings that bears the risk of infection. PeriSafe is a connection device that is making home dialysis easier and safer for all home dialysis patients and it especially supports elderly and frail individuals. Peripal announced today that it has closed a Series B financing round with strong participation from existing investors including StartAngels, Zürcher Kantonalbank, family offices and wealthy individuals. The company also welcomes its new anchor investor FortyOne Group, a Swiss Private Equity Company. “We will use the funding to drive the broad launch and market penetration of our PeriSafe system and to finance new development projects”, says Dr. Sandra Neumann, founder and CEO of Peripal AG. The current market volume of home peritoneal dialysis is $ 3.2bn and it is growing at 6% annually until 2025, driven by age, diabetes and hypertension. “There is still a lot of unserved potential to shift patients to home dialysis, because home dialysis patients have a better quality of life, more flexibility and less dietary restrictions”, states Reto Koch, Chairman of the Board. Chronic kidney failure increases at a rate of 2-4% annually, driven by age, diabetes, and hypertension. With the support of Peripal AG’s patient aid, more patients can receive their therapy in a home setting as opposed to the hospital, resulting in considerable healthcare cost reductions and, improved safety and quality of life. (Press release)